logo
Select company
Select metric
$ -264.84MInvested Capital
VS
Market
0
Sector
0
Industry
0
History
-
$ 3.88Close
$ 1.5 - $ 7.06 52-Week Range
Ticker Information

Ticker

AGEN

Company Name

AGENUS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

AGENUS INC - Invested Capital Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

AGEN - Inv. Capital Historical data
DateTotal DebtShareholders EquityInvested Capital
6/30/2025$ 89.76M$ -354.6M$ -264.84M
3/31/2025$ 90.08M$ -341.85M$ -251.76M
12/31/2024$ 90.17M$ -326.38M$ -236.21M
9/30/2024$ 70.99M$ -292.34M$ -221.34M
6/30/2024$ 71.51M$ -241.31M$ -169.8M
3/31/2024$ 78.14M$ -201.43M$ -123.29M
12/31/2023$ 78.01M$ -160.33M$ -82.32M
9/30/2023$ 78.83M$ -129.11M$ -50.28M
6/30/2023$ 77.45M$ -93.19M$ -15.74M
3/31/2023$ 78.48M$ -58.54M$ 19.94M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • AGENUS INC's latest trailing twelve months (TTM) Inv. Capital stands at $ -161.74M.
  • Over the past 5 years, AGENUS INC's average Inv. Capital has been $ -79.94M.
  • The median Inv. Capital for AGENUS INC during this period was $ -102.8M
  • AGENUS INC reached its highest Inv. Capital over the past 5 years at $ 96.45M.
  • The lowest Inv. Capital recorded by AGENUS INC in the same timeframe $ -264.84M

AGENUS INC's Inv. Capital vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Inv. Capital Benchmarks
CompanyInv. Capital
SGMO : SANGAMO THERAPEUTICS INC $ 43.06MALEC : ALECTOR INC $ 110.66MBDTX : BLACK DIAMOND THERAPEUTICS INC $ 149.58MTHTX : THERATECHNOLOGIES INC $ 11.46MPLX : PROTALIX BIOTHERAPEUTICS INC $ 55.25MSTRO : SUTRO BIOPHARMA INC $ -12.52MSPRO : SPERO THERAPEUTICS INC $ 36.44MENTA : ENANTA PHARMACEUTICALS INC $ 137.33MCSBR : CHAMPIONS ONCOLOGY INC $ 9.26MCHRS : COHERUS ONCOLOGY INC $ 159.1M

Definition of Invested Capital

[Calculation] Invested Capital is the total amount of money raised by a business in the form [Equity] and/or [Debt].
Debt + Equity
(=) Inv. Capital
Inv. Capital for AGENUS INC is calculated as follows: Debt [ $ 36.75M ] + Equity [ $ -198.49M ]
(=) Inv. Capital [ $ -161.74M ]

AGEN - Invested Capital, Last 5 years

$ -264.84M

Minimum

Jun 30, 2025

$ 96.45M

Maximum

Sep 30, 2021

$ -79.94M

Average

$ -102.8M

Median

Inv. Capital Benchmark Analysis

The chart above depicts the distribution of Inv. Capital for companies in the Total Stock Market. The average Inv. Capital of the companies is $ 760.31M with a standard deviation of $ 1B.
The following table provides additional summary stats:
Inv. Capital in the Market:
filtered constituents3.44K
min$ -1.51B
max$ 4.11B
average$ 760.31M
median$ 303.21M
std$ 1B